| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Technology Officer | Chief Technology Officer
1 company
Harmon Cyrus is a Director at Olema Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $11.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 3,489 | $29.12 | $101,599.68 | -0.5% | -44.0% | - | |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 2,881 | $28.53 | $82,194.93 | -0.4% | -50.4% | - | |
| Sep 18, 2025 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $8.19 | $204,840.64 | -1.4% | +283.1% | - | |
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 16,393 | $9.03 | $147,955.81 | -0.7% | -48.5% | +275.5% | |
| Jul 30, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 5,000 | $15.57 | $77,871.98 | -0.3% | -24.5% | -67.4% | |
| Jul 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 5,000 | $12.26 | $61,300.00 | -0.7% | -9.9% | -62.8% | |
| Jun 28, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 20,000 | $10.77 | $215,400.00 | -2.6% | +12.9% | -57.3% | |
| Jun 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $10.30 | $257,450.00 | -1.0% | -18.9% | -69.8% | |
| May 6, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 5,000 | $10.92 | $54,600.00 | -0.6% | +27.2% | -57.8% | |
| Apr 30, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 15,000 | $9.51 | $142,650.00 | -1.8% | +49.4% | -49.3% |